| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 49, 538-542, Copyright © 1979 by Endocrine Society
ARTICLES |
LJ DeGroot and PA Rue
The ability of roentgenographic contrast agents to inhibit binding of [125I]T3 to nuclear receptors was studied during incubation of rat liver nuclei or nuclear extracts in vitro and after ip administration of the agents in vivo. Ipodate, iodipamide, iopanoic acid, and diatrizoate inhibited binding of [125I]T3 in vitro. The most potent inhibitor was ipodate, which produced 50% inhibition of binding at 1.2 X 10(-4) M. When given orally in acute in vivo experiments, ipodate did not diminish binding to liver nuclear receptors. Ipodate appeared to inhibit in vivo metabolism of [125I]T3.
This article has been cited by other articles:
![]() |
C. S. Bal, A. Kumar, and P. Chandra Effect of Iopanoic Acid on Radioiodine Therapy of Hyperthyroidism: Long-Term Outcome of a Randomized Controlled Trial J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6536 - 6540. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. J. Chopra and K. Baber Use of Oral Cholecystographic Agents in the Treatment of Amiodarone-Induced Hyperthyroidism J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4707 - 4710. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Braga and D. S. Cooper Oral Cholecystographic Agents and the Thyroid J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 1853 - 1860. [Abstract] [Full Text] |
||||
![]() |
K. B. Becker, K. C. Stephens, J. C. Davey, M. J. Schneider, and V. A. Galton The Type 2 and Type 3 Iodothyronine Deiodinases Play Important Roles in Coordinating Development in Rana catesbeiana Tadpoles Endocrinology, July 1, 1997; 138(7): 2989 - 2997. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |